Mallinckrodt to acquire Cadence Pharmaceuticals

09:09 AM | February 13, 2014 | Natasha Alperowicz

Mallinckrodt, a specialty pharmaceutical and medical imaging group, says that it has entered into a definitive agreement to acquire all outstanding shares of Cadence Pharmaceuticals for $14.00/share...